Skip to content

Clinical trials

Phase 3 Lymphoma, Mantle-Cell trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Phase: Phase 3 Country / region: Netherlands Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20121
20133
20171
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC3
European Organisation for Research and Treatment of Cancer - EORTC2
BeOne Medicines1
Commissie Voor Klinisch Toegepast Onderzoek1
European Mantle Cell Lymphoma Network1
Loxo Oncology, Inc.1
Pharmacyclics LLC.1
The Lymphoma Academic Research Organisation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell11
Lymphoma, Non-Hodgkin5
Lymphoma, Follicular4
Lymphoma, Large B-Cell, Diffuse4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma3
Burkitt Lymphoma2
Leukemia, Myeloid, Acute2
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Large-Cell, Immunoblastic2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.